Hims & Hers: A Rare GARP Setup After The Market Reset (NYSE:HIMS)

Does the ~45% correction in Hims & Hers Health ( HIMS ) open up a great opportunity for investors who missed the 2024-25 rally? My view is that it does. The markets have come down heavilyI am a stock analyst with over 20 years of experience in quantitative research, financial modeling, and risk management. My focus is on equity valuation, market trends, and portfolio optimization to uncover high-growth investment opportunities. As a former Vice President at Barclays, I led teams in model validation, stress ...